TR201903889T4 - Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem. - Google Patents
Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem. Download PDFInfo
- Publication number
- TR201903889T4 TR201903889T4 TR2019/03889T TR201903889T TR201903889T4 TR 201903889 T4 TR201903889 T4 TR 201903889T4 TR 2019/03889 T TR2019/03889 T TR 2019/03889T TR 201903889 T TR201903889 T TR 201903889T TR 201903889 T4 TR201903889 T4 TR 201903889T4
- Authority
- TR
- Turkey
- Prior art keywords
- endothelial cells
- directed differentiation
- corneal endothelial
- cells
- corneal
- Prior art date
Links
- 210000000399 corneal endothelial cell Anatomy 0.000 title abstract 2
- 230000004069 differentiation Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 208000013521 Visual disease Diseases 0.000 abstract 1
- 208000021921 corneal disease Diseases 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 208000029257 vision disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/08—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Bu tarifname genellikle, kornea bozuklukları dahil olmak üzere görsel bozuklukların tedavisine yönelik hücre esaslı terapiler ile ilgilidir. Yöntemler, korneal hücrelerin kök hücrelerden yönlendirilmiş diferansiyasyonu örneklendirmektedir. Korneal endotelyal hücrelerin bileşimleri ve bunların kullanımı da sağlanmaktadır. Örnek niteliğindeki bileşimler, iyileştirilmiş hücre yoğunluğu ve/veya bağışlanan dokudan elde edilen hücrelere göre daha "genç" gen ifadesini sergilemektedir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161567479P | 2011-12-06 | 2011-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201903889T4 true TR201903889T4 (tr) | 2019-04-22 |
Family
ID=48575057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/03889T TR201903889T4 (tr) | 2011-12-06 | 2012-12-06 | Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem. |
Country Status (15)
Country | Link |
---|---|
US (2) | US9752118B2 (tr) |
EP (2) | EP2788472B1 (tr) |
CA (2) | CA2858173C (tr) |
CY (1) | CY1121383T1 (tr) |
DK (1) | DK2788472T3 (tr) |
ES (1) | ES2716200T3 (tr) |
HR (1) | HRP20190460T1 (tr) |
HU (1) | HUE041929T2 (tr) |
LT (1) | LT2788472T (tr) |
PL (1) | PL2788472T3 (tr) |
PT (1) | PT2788472T (tr) |
RS (1) | RS58526B1 (tr) |
SI (1) | SI2788472T1 (tr) |
TR (1) | TR201903889T4 (tr) |
WO (1) | WO2013086236A2 (tr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10842669B2 (en) * | 2008-11-13 | 2020-11-24 | Gholam A. Peyman | Ophthalmic drug delivery method |
JP6519851B2 (ja) * | 2012-07-06 | 2019-05-29 | 京都府公立大学法人 | 眼細胞の分化マーカーおよび分化制御 |
WO2014179716A2 (en) * | 2013-05-03 | 2014-11-06 | Emmetrope Ophthalmics Llc | IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECs) |
WO2015016371A1 (ja) | 2013-07-30 | 2015-02-05 | 京都府公立大学法人 | 角膜内皮細胞マーカー |
US11730722B2 (en) | 2013-07-30 | 2023-08-22 | Kyoto Prefectural Public University Corporation | Corneal endothelium ECM therapeutic medicaments |
EP3031906A4 (en) * | 2013-08-06 | 2017-01-25 | Riken | Method for producing anterior eye segment tissue |
WO2015041606A1 (en) * | 2013-09-17 | 2015-03-26 | Singapore Health Services Pte Ltd | Corneal stromal keratocyte culture |
US11382904B2 (en) | 2013-10-31 | 2022-07-12 | Kyoto Prefectural Public University Corporation | Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium |
WO2015080297A1 (en) * | 2013-11-27 | 2015-06-04 | Kyoto Prefectural Public University Corporation | Application of laminin to corneal endothelial cell culture |
EP3213761B1 (en) | 2014-10-31 | 2021-05-19 | Kyoto Prefectural Public University Corporation | Novel treatment of retina using laminin |
JP6925805B2 (ja) * | 2014-10-31 | 2021-08-25 | 京都府公立大学法人 | ラミニンによる角膜の新規治療 |
IL303401A (en) | 2015-03-23 | 2023-08-01 | Astellas Inst For Regenerative Medicine | Improved assays for the potential of retinal pigment epithelium (RPE) cells and photoreceptor progenitors |
AU2016308818B2 (en) | 2015-08-18 | 2022-04-21 | Astellas Institute For Regenerative Medicine | Clinical formulations |
US11781110B2 (en) | 2016-04-29 | 2023-10-10 | The Regents Of The University Of California | Induction of corneal endothelial cells |
US20200032202A1 (en) * | 2017-04-04 | 2020-01-30 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | A modified cell culture medium and uses thereof |
US11433090B2 (en) | 2017-06-16 | 2022-09-06 | The Doshisha | mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
US20200121652A1 (en) * | 2017-06-16 | 2020-04-23 | The Doshisha | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
CN107475200B (zh) * | 2017-08-08 | 2020-12-22 | 浙江大学 | 一种背根神经节源的神经嵴干细胞的分离、培养与分化方法 |
KR102010478B1 (ko) * | 2017-11-01 | 2019-08-13 | 차의과학대학교 산학협력단 | 줄기 세포의 신경 능선 세포로의 분화용 조성물, 키트, 및 이를 이용한 방법 |
AU2018371437A1 (en) * | 2017-11-24 | 2020-07-02 | Sumitomo Chemical Company, Limited | Production method for cell mass including neural cells/tissue and non-neural epithelial tissue, and cell mass from same |
KR102114787B1 (ko) * | 2018-04-02 | 2020-05-26 | 중앙대학교 산학협력단 | 리보핵산분해효소 5 고발현된 각막 내피세포를 포함하는 3차원 각막 내피 이식체 제조방법 |
JP7474520B2 (ja) * | 2019-04-05 | 2024-04-25 | ザ・ユニバーシティ・オブ・ホンコン | 哺乳類の拡大ポテンシャル幹細胞のための培地、その組成物および方法 |
WO2020213969A2 (ko) * | 2019-04-17 | 2020-10-22 | 연세대학교 산학협력단 | 각막 내피 세포의 기능 부전 진단용 바이오마커 |
AU2022270611A1 (en) | 2021-05-03 | 2023-10-12 | Astellas Institute For Regenerative Medicine | Methods of generating mature corneal endothelial cells |
CN113355424B (zh) * | 2021-07-14 | 2022-03-25 | 江苏先声医学诊断有限公司 | Pcdh11x突变在预测非小细胞肺癌患者对免疫检查点抑制剂疗法敏感性中的应用 |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3421217A (en) | 1967-06-29 | 1969-01-14 | Schick Electric Inc | Hair receptacle for electric shaver |
US5166048A (en) | 1981-03-02 | 1992-11-24 | Soll David B | Protection of human corneal endothelial cells |
US4678783B1 (en) | 1983-11-04 | 1995-04-04 | Asahi Chemical Ind | Substituted isoquinolinesulfonyl compounds |
US4959319A (en) | 1985-08-01 | 1990-09-25 | Skelnik Debra L | Process of corneal enhancement |
US5269812A (en) | 1986-05-16 | 1993-12-14 | White Thomas C | Methods and devices employed in replacement of the corneal endothelium |
AU8532691A (en) | 1990-08-01 | 1992-03-02 | Chiron Ophthalmics Inc. | Method for treating corneal endothelial wounds |
US5589451A (en) | 1992-09-21 | 1996-12-31 | Board Of Regents, The University Of Texas System | Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors |
US5703047A (en) | 1992-09-21 | 1997-12-30 | Board Of Regents, The University Of Texas System | Methods and treatments for corneal healing with growth factors |
US5649944A (en) | 1994-08-12 | 1997-07-22 | Collins; Joseph Patrick | Apparatus for preparing cornea material for tabbed (sutureless) transplantation |
US5584881A (en) | 1994-08-12 | 1996-12-17 | Rowsey; J. James | Sutureless corneal transplantation apparatus and method |
US5755785A (en) | 1994-08-12 | 1998-05-26 | The University Of South Florida | Sutureless corneal transplantation method |
US5686414A (en) | 1995-11-14 | 1997-11-11 | Xoma Corporation | Methods of treating conditions associated with corneal transplantation |
JP2001508302A (ja) | 1997-01-10 | 2001-06-26 | ライフ テクノロジーズ,インコーポレイテッド | 胚性幹細胞血清置換 |
WO1999020620A1 (fr) | 1997-10-22 | 1999-04-29 | Nippon Shinyaku Co Ltd | Derive d'isoquinoleine et medicament |
WO1999061403A1 (fr) | 1998-05-25 | 1999-12-02 | Santen Pharmaceutical Co., Ltd. | Nouveaux derives vinylbenzene |
US6541256B1 (en) | 1999-02-11 | 2003-04-01 | The Schepens Eye Research Institute, Inc. | Growth medium for human corneal endothelial cells |
US6548059B1 (en) | 1999-07-22 | 2003-04-15 | The Schepens Eye Research Institute, Inc. | Promotion of proliferation of adult corneal endothelial cells |
AUPR069500A0 (en) * | 2000-10-11 | 2000-11-09 | Coster, Douglas John | Tissue modification |
AU2002245709A1 (en) | 2001-03-23 | 2002-10-08 | Bayer Corporation | Rho-kinase inhibitors |
AR035791A1 (es) | 2001-03-23 | 2004-07-14 | Bayer Corp | Compuesto n,n-diheterociclico de amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y proceso para la preparacion del compuesto |
EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
AU2003202263A1 (en) | 2002-01-10 | 2003-07-30 | Bayer Healthcare Ag | Roh-kinase inhibitors |
US6943172B2 (en) | 2002-01-23 | 2005-09-13 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
WO2003092762A1 (fr) * | 2002-04-30 | 2003-11-13 | Amniotec Inc. | Feuille de type endothelium corneen et procede permettant de la produire |
CN100354264C (zh) | 2002-07-22 | 2007-12-12 | 旭化成制药株式会社 | 5-取代异喹啉衍生物及含有它们的药物 |
DE10237945A1 (de) | 2002-08-20 | 2004-03-11 | Quintis Gmbh | Laserbasierte Vorrichtung zur nichtmechanischen, dreidimensionalen Trepanation bei Hornhauttransplantationen |
CA2400996A1 (en) | 2002-09-03 | 2004-03-03 | Lisa Mckerracher | 1,4-substituted cyclohexane derivatives |
EP2230298A1 (en) | 2003-02-06 | 2010-09-22 | Cellseed Inc. | Anterior ocular segment related cell sheets, three-dimensional structures, and processes for producing the same |
EP1600177B1 (en) | 2003-02-20 | 2016-05-25 | Cellseed Inc. | Endothelial cell sheet for cornea regeneration, method of producing the same and method of using the same |
WO2004106378A2 (en) | 2003-05-28 | 2004-12-09 | Regeneron Pharmaceuticals, Inc. | Method of treating corneal transplant rejection by using vegf antagonists |
US7300654B2 (en) | 2003-05-28 | 2007-11-27 | Regeneron Pharmaceuticals, Inc. | Method of treating corneal transplant rejection in high risk keratoplasty patients |
US7160894B2 (en) | 2003-06-06 | 2007-01-09 | Asahi Kasei Pharma Corporation | Tricyclic compound |
JP2007516196A (ja) | 2003-07-02 | 2007-06-21 | ガラパゴス エヌブイ | Rhoキナーゼ阻害剤としてのピラジン及びピラリジン誘導体 |
US7147648B2 (en) | 2003-07-08 | 2006-12-12 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Device for cutting and holding a cornea during a transplant procedure |
US20050182061A1 (en) | 2003-10-02 | 2005-08-18 | Jeremy Green | Phthalimide compounds useful as protein kinase inhibitors |
WO2005037197A2 (en) | 2003-10-06 | 2005-04-28 | Glaxo Group Limited | Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
EP1689393A4 (en) | 2003-10-06 | 2008-12-17 | Glaxo Group Ltd | PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS |
EP1670466A4 (en) | 2003-10-06 | 2007-04-25 | Glaxo Group Ltd | PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS |
US20070275365A1 (en) | 2003-10-10 | 2007-11-29 | Lui Ge M | Human Corneal Endothelial Cells and Methods of Obtaining and Culturing Cells for Corneal Cell Transplantation |
JP2007509643A (ja) | 2003-10-10 | 2007-04-19 | ゲ・ミン・ルイ | 角膜内皮および関連細胞のバイオポリマー上での増殖のための方法および組成物ならびに人工角膜移植片の作成 |
JP2007015928A (ja) | 2003-10-15 | 2007-01-25 | Ube Ind Ltd | 新規オレフィン誘導体 |
JP4110324B2 (ja) | 2003-10-15 | 2008-07-02 | 宇部興産株式会社 | 新規インダゾール誘導体 |
JP2007008816A (ja) | 2003-10-15 | 2007-01-18 | Ube Ind Ltd | 新規イソキノリン誘導体 |
US7087369B2 (en) | 2003-12-17 | 2006-08-08 | The Regents Of The University Of California | Cornea preservation medium |
JP4834802B2 (ja) | 2004-02-18 | 2011-12-14 | 聡 山上 | ヒト角膜内皮細胞の培養物層積層体及びその作製方法 |
CN1980929A (zh) | 2004-02-24 | 2007-06-13 | 比奥阿克松医疗技术股份有限公司 | 4-取代哌啶衍生物 |
US20060216821A1 (en) * | 2004-02-26 | 2006-09-28 | Reliance Life Sciences Pvt. Ltd. | Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof |
KR20070002081A (ko) | 2004-04-02 | 2007-01-04 | 버텍스 파마슈티칼스 인코포레이티드 | Rock 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌 |
JP2006006249A (ja) * | 2004-06-28 | 2006-01-12 | Hiroshima Univ | 羊膜由来細胞の培養方法及びその利用 |
BRPI0513897A (pt) * | 2004-07-29 | 2008-05-20 | Stem Cell Innovations Inc | diferenciação de células-tronco |
JPWO2006057270A1 (ja) | 2004-11-26 | 2008-06-05 | 旭化成ファーマ株式会社 | 含窒素3環化合物 |
EP1835023A4 (en) * | 2004-12-09 | 2008-09-10 | Amano Shiro | PRECIPITATING CELL DERIVED FROM HUMAN HORNHAIL ENTHELIAL CELLS, OR DERIVED CELL ASSOCIATION, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD FOR TRANSPLANTING THE PRECURSOR CELL OR THE CELL ASSOCIATION |
US9999497B2 (en) | 2005-01-31 | 2018-06-19 | Yichieh Shiuey | Corneal implants and methods and systems for placement |
US7601487B2 (en) | 2005-04-12 | 2009-10-13 | Cleo Cosmetic And Pharmaceutical Co., Llc | Composition using HMW dextran and method for in vitro preservation of corneal tissues |
CN101253166B (zh) | 2005-08-30 | 2013-07-10 | 旭化成制药株式会社 | 磺酰胺化合物 |
EP1945759A1 (en) | 2005-10-12 | 2008-07-23 | Cellular Bioengineering, Inc. | Resorbable cornea button |
US20070128722A1 (en) * | 2005-12-05 | 2007-06-07 | Industrial Technology Research Institute | Human mesenchymal stem cells and culturing methods thereof |
WO2007083685A1 (ja) | 2006-01-19 | 2007-07-26 | Senju Pharmaceutical Co., Ltd. | 生体内で細胞増殖可能な角膜内皮製剤 |
TWI407967B (zh) | 2006-04-28 | 2013-09-11 | Ray Jui Fang Tsai | 人類角膜內皮幹細胞之擴增方法 |
US20080050423A1 (en) | 2006-08-23 | 2008-02-28 | National Tsing Hua University | Biopolymer-bioengineered cell sheet construct |
JP5391488B2 (ja) * | 2006-09-28 | 2014-01-15 | ティシューテック・インコーポレイテッド | 接着結合を持つ細胞の増殖を刺激するRNAi方法および組成物 |
US20100022517A1 (en) * | 2006-12-18 | 2010-01-28 | Richards Lori A | Ophthalmic formulation of rho kinase inhibitor compound |
US8071779B2 (en) * | 2006-12-18 | 2011-12-06 | Inspire Pharmaceuticals, Inc. | Cytoskeletal active rho kinase inhibitor compounds, composition and use |
EP2177602B1 (en) * | 2007-07-13 | 2013-09-11 | Mitsubishi Tanabe Pharma Corporation | Method for isolation of cell, serum-free culture medium for cell, and method for culture of cell |
RU2473685C2 (ru) * | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
CA2697895C (en) | 2007-08-29 | 2017-10-31 | Senju Pharmaceutical Co., Ltd. | Agent for promoting corneal endothelial cell adhesion |
US20100297234A1 (en) * | 2007-10-19 | 2010-11-25 | Ilene Sugino | Method of using an extracellular matrix to enhance cell transplant survival and differentiation |
EP2209471A4 (en) | 2007-10-30 | 2010-11-10 | Univ Louisiana State | PROTECTION OF LIPOXIN A4 FOR ENDOTHELIAL CORNEAL CELLS |
WO2009132212A2 (en) | 2008-04-25 | 2009-10-29 | The Regents Of The University Of California | Device to store and inject corneal graft |
JP5305066B2 (ja) * | 2008-05-09 | 2013-10-02 | 国立大学法人大阪大学 | 組織幹細胞/組織前駆細胞からの角膜内皮細胞の生成方法 |
US20100184033A1 (en) * | 2008-07-16 | 2010-07-22 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
WO2008155748A2 (en) | 2008-09-04 | 2008-12-24 | Massimo Busin | A new technique for preparing, storing and transplanting endothelial grafts |
WO2010084970A1 (ja) * | 2009-01-23 | 2010-07-29 | 国立大学法人大阪大学 | 標的細胞誘導用フィーダー細胞 |
US8642334B2 (en) * | 2009-02-17 | 2014-02-04 | Memorial Sloan Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
WO2010099310A1 (en) | 2009-02-26 | 2010-09-02 | Wake Forest University Health Sciences | Endothelial scaffolds |
WO2010108126A2 (en) * | 2009-03-19 | 2010-09-23 | Fate Therapeutics, Inc. | Reprogramming compositions and methods of using the same |
EP2468312A4 (en) * | 2009-08-19 | 2014-05-14 | Univ Tohoku | SHEET FOR KERATOPLASTIES |
US20120219535A1 (en) * | 2009-10-02 | 2012-08-30 | University Of Southern California | Cranial neural crest stem cells and culture condition that supports their growth |
US20110143415A1 (en) * | 2009-12-14 | 2011-06-16 | Sergei Paylian | Reprogramming normal and cancerous human cell lines into human induced poluripotent stem cells by co-electroporation with living xenopus laevis frog oocytes |
WO2011080984A1 (en) * | 2009-12-29 | 2011-07-07 | Senju Pharmaceutical Co., Ltd. | Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
WO2011096593A1 (ja) * | 2010-02-05 | 2011-08-11 | 財団法人先端医療振興財団 | 角膜内皮細胞の培養方法、移植用角膜内皮細胞シートの製造方法および角膜内皮細胞培養キット |
WO2011142364A1 (ja) * | 2010-05-10 | 2011-11-17 | 独立行政法人理化学研究所 | 細胞シート作製方法 |
PL2577318T3 (pl) * | 2010-05-25 | 2019-12-31 | Memorial Sloan-Kettering Cancer Center | Sposób różnicowania ludzkich embrionalnych komórek macierzystych do nocyceptorów i ich zastosowania |
CA2806127C (en) | 2010-07-23 | 2021-12-21 | Advanced Cell Technology, Inc. | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
US20120028933A1 (en) * | 2010-07-28 | 2012-02-02 | Baust John M | Cell Culture Media Supplement and Method of Molecular Stress Control |
WO2012135621A2 (en) | 2011-03-30 | 2012-10-04 | Cellular Dynamics International. Inc | Priming of pluripotent stem cells for neural differentiation |
WO2013012087A1 (ja) * | 2011-07-15 | 2013-01-24 | 国立大学法人大阪大学 | 角膜内皮細胞の調製方法 |
US9347042B2 (en) * | 2011-10-06 | 2016-05-24 | Keio University | Method for producing corneal endothelial cell |
-
2012
- 2012-12-06 ES ES12856068T patent/ES2716200T3/es active Active
- 2012-12-06 PT PT12856068T patent/PT2788472T/pt unknown
- 2012-12-06 SI SI201231565T patent/SI2788472T1/sl unknown
- 2012-12-06 CA CA2858173A patent/CA2858173C/en active Active
- 2012-12-06 RS RS20190371A patent/RS58526B1/sr unknown
- 2012-12-06 HU HUE12856068A patent/HUE041929T2/hu unknown
- 2012-12-06 US US14/362,775 patent/US9752118B2/en active Active
- 2012-12-06 TR TR2019/03889T patent/TR201903889T4/tr unknown
- 2012-12-06 WO PCT/US2012/068305 patent/WO2013086236A2/en active Application Filing
- 2012-12-06 DK DK12856068.7T patent/DK2788472T3/en active
- 2012-12-06 EP EP12856068.7A patent/EP2788472B1/en active Active
- 2012-12-06 EP EP18215237.1A patent/EP3517604A1/en active Pending
- 2012-12-06 LT LTEP12856068.7T patent/LT2788472T/lt unknown
- 2012-12-06 PL PL12856068T patent/PL2788472T3/pl unknown
- 2012-12-06 CA CA3178138A patent/CA3178138A1/en active Pending
-
2017
- 2017-08-01 US US15/666,518 patent/US20180072989A1/en active Pending
-
2019
- 2019-03-08 HR HRP20190460TT patent/HRP20190460T1/hr unknown
- 2019-03-15 CY CY20191100314T patent/CY1121383T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK2788472T3 (en) | 2019-04-08 |
US9752118B2 (en) | 2017-09-05 |
CA2858173C (en) | 2023-09-26 |
EP2788472A2 (en) | 2014-10-15 |
CA2858173A1 (en) | 2013-06-13 |
WO2013086236A3 (en) | 2013-08-01 |
ES2716200T3 (es) | 2019-06-11 |
US20180072989A1 (en) | 2018-03-15 |
HUE041929T2 (hu) | 2019-06-28 |
CY1121383T1 (el) | 2020-05-29 |
SI2788472T1 (sl) | 2019-04-30 |
CA3178138A1 (en) | 2013-06-13 |
HRP20190460T1 (hr) | 2019-04-19 |
EP2788472A4 (en) | 2015-07-29 |
LT2788472T (lt) | 2019-04-10 |
EP3517604A1 (en) | 2019-07-31 |
PT2788472T (pt) | 2019-04-01 |
EP2788472B1 (en) | 2019-02-20 |
RS58526B1 (sr) | 2019-04-30 |
US20140370007A1 (en) | 2014-12-18 |
WO2013086236A2 (en) | 2013-06-13 |
PL2788472T3 (pl) | 2019-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201903889T4 (tr) | Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem. | |
MX2017004890A (es) | Metodos y composiciones para la generación o el mantenimiento de células pluripotentes. | |
NZ609731A (en) | Compositions of adult organ stem cells and uses thereof | |
MX2023001878A (es) | Celulas modificadas geneticamente que comprenden un gen humano modificado de la region constante alfa del receptor de celulas t. | |
WO2012020308A3 (en) | Pancreatic duct progenitor cells and microrna obtained therefrom for use in tissue regeneration | |
UA111756C2 (uk) | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона | |
CY1123343T1 (el) | Παραγωγη μιας τραπεζας μεσεγχυματικων στρωματικων κυτταρων απο τα ομαδοποιημενα μονοπυρηνα κυτταρα πολλαπλων δοτων μυελου των οστων | |
WO2010141801A3 (en) | Reprogramming t cells and hematophietic cells | |
EA201391154A3 (ru) | Способы и композиции для нацеливания на адипоциты у млекопитающих | |
MX339709B (es) | Antagonistas de wnt y metodos de tratamiento y analisis. | |
WO2013124815A3 (en) | Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof | |
MX2023003296A (es) | Generacion de lineas de cardiomiocitos auriculares y ventriculares a partir de celulas madre pluripotentes humanas. | |
BR112015009229A2 (pt) | composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada | |
WO2011056017A3 (ko) | 모낭 줄기세포의 대량 증식 방법 | |
WO2013025446A3 (en) | Anti-fzd10 monoclonal antibodies and methods for their use | |
IN2014DN06603A (tr) | ||
HK1157814A1 (en) | Materials and methods relating to cell based therapies | |
WO2012079088A3 (en) | Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases | |
WO2011028880A3 (en) | Methods for enhancing genome stability and telomere elongation in embryonic stem cells | |
WO2012075462A3 (en) | Methods and compositions for treatment of muscular dystrophy | |
WO2011043629A3 (ko) | 인간 지방 줄기세포의 고활성을 유도하는 방법 및 배지 | |
CA2837895C (en) | Methods of treating or preventing neurological diseases | |
WO2014072720A3 (en) | Cell differentiation | |
SG195170A1 (en) | Methods of treating or preventing rheumatic disease | |
MX2014003094A (es) | Metodos para promover diferenciacion. |